Applitech hold a products and technology exchange at Wuhan institute of Biotechnology on July 16^th,2014. We had face-to-face communication with research personnel from Wuhan institute in the aspects of new vaccines, monoclonal antibodies and other biotechnology research and bioreactor platform in pilot scale transformation process, animal cell culture technology, process analysis and scale-up.

Applitech is devoted to the optimization, amplification and industrialization of biological process with a complete product line in the field of biology and medicine. Wuhan institute is mainly engaged in biotechnology R&D, professional services and achievements transformation. It is the national biological industry base. Applitech hopes to provide products support and technology exchange in the aspects of technology innovation and achievements transformation, to contribute to the development of biotechnology industry.